GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (FRA:OFK) » Definitions » Valuation Rank

Orion Oyj (FRA:OFK) Valuation Rank


View and export this data going back to 2006. Start your Free Trial

What is Orion Oyj Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Orion Oyj Valuation Rank Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Oyj Business Description

Address
Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.